These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25946527)

  • 1. [Prevalence, associated factors and phenomenology of psychosis in patients with Parkinson's disease].
    Rodríguez-Violante M; Velázquez-Osuna S; Cervantes-Arriaga A; Corona-Vázquez T; de la Fuente-Sandoval C
    Gac Med Mex; 2015; 151(2):169-75. PubMed ID: 25946527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of neuropsychiatric disorders in drug-naive subjects with Parkinson's disease (PD)].
    Isais-Millán S; Piña-Fuentes D; Guzmán-Astorga C; Cervantes-Arriaga A; Rodríguez-Violante M
    Gac Med Mex; 2016; 152(3):357-63. PubMed ID: 27335192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hallucinations and psychosis in Parkinson's disease.
    Rabey JM
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S105-10. PubMed ID: 20123547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
    Kulick CV; Montgomery KM; Nirenberg MJ
    Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of psychosis in Parkinson's disease.
    Fénelon G; Alves G
    J Neurol Sci; 2010 Feb; 289(1-2):12-7. PubMed ID: 19740486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychosis in Parkinson's disease].
    Rongve A; Auning E; Ehrt U; Arsland D
    Tidsskr Nor Laegeforen; 2012 Jan; 132(2):155-8. PubMed ID: 22278271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scales to evaluate psychosis in Parkinson's disease.
    Goetz CG
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S38-41. PubMed ID: 20083004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
    Ojagbemi A
    J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hallucinations and the spectrum of psychosis in Parkinson's disease.
    Frei K; Truong DD
    J Neurol Sci; 2017 Mar; 374():56-62. PubMed ID: 28108020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.
    Giladi N; Treves TA; Paleacu D; Shabtai H; Orlov Y; Kandinov B; Simon ES; Korczyn AD
    J Neural Transm (Vienna); 2000; 107(1):59-71. PubMed ID: 10809404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychosis in Parkinson's disease.
    Thanvi BR; Lo TC; Harsh DP
    Postgrad Med J; 2005 Oct; 81(960):644-6. PubMed ID: 16210460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
    Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
    Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein epsilon4 advances appearance of psychosis in patients with Parkinson's disease.
    Feldman B; Chapman J; Korczyn AD
    Acta Neurol Scand; 2006 Jan; 113(1):14-7. PubMed ID: 16367893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotic symptoms in Parkinson's disease: pathophysiology and management.
    Bosboom JL; Wolters ECh
    Expert Opin Drug Saf; 2004 May; 3(3):209-20. PubMed ID: 15155149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis associated to Parkinson's disease in the early stages: relevance of cognitive decline and depression.
    Morgante L; Colosimo C; Antonini A; Marconi R; Meco G; Pederzoli M; Pontieri FE; Cicarelli G; Abbruzzese G; Zappulla S; Ramat S; Manfredi M; Bottacchi E; Abrignani M; Berardelli A; Cozzolino A; Paradiso C; De Gaspari D; Morgante F; Barone P;
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):76-82. PubMed ID: 21836035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of onset of psychosis in patients with Parkinson's disease: Who gets it early?
    Lenka A; George L; Arumugham SS; Hegde S; Reddy V; Kamble N; Yadav R; Pal PK
    Parkinsonism Relat Disord; 2017 Nov; 44():91-94. PubMed ID: 28928050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scales to assess psychosis in Parkinson's disease: Critique and recommendations.
    Fernandez HH; Aarsland D; Fénelon G; Friedman JH; Marsh L; Tröster AI; Poewe W; Rascol O; Sampaio C; Stebbins GT; Goetz CG
    Mov Disord; 2008 Mar; 23(4):484-500. PubMed ID: 18175343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase.
    Pagonabarraga J; Martinez-Horta S; Fernández de Bobadilla R; Pérez J; Ribosa-Nogué R; Marín J; Pascual-Sedano B; García C; Gironell A; Kulisevsky J
    Mov Disord; 2016 Jan; 31(1):45-52. PubMed ID: 26408291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease psychosis: presentation, diagnosis and management.
    Schneider RB; Iourinets J; Richard IH
    Neurodegener Dis Manag; 2017 Dec; 7(6):365-376. PubMed ID: 29160144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.